RCAMU
CBST

Rothschild & Co Asset Management US’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Rothschild & Co Asset Management US’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,832
Closed -$2.1M – 364
2014
Q4 		$2.1M Sell
20,832
-117,442
-85% -$9.13M 0.04% 317
2014
Q3 		$9.17M Sell
138,274
-6,570
-5% -$432K 0.2% 165
2014
Q2 		$10.1M Sell
144,844
-3,714
-3% -$253K 0.21% 162
2014
Q1 		$10.9M Sell
148,558
-15,627
-10% -$1.17M 0.24% 137
2013
Q4 		$11.3M Buy
164,185
+3,925
+2% +$254K 0.25% 136
2013
Q3 		$10.2M Sell
160,260
-24,347
-13% -$1.47M 0.22% 157
2013
Q2 		$8.91M Buy
+184,607
New +$9.07M 0.21% 167

Rothschild & Co Asset Management US's CBST Position: Q1 2015 in Review

Rothschild & Co Asset Management US sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 20,832 shares — an estimated $2.1M sold.

Rothschild & Co Asset Management US first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $11.3M in Q4 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Rothschild & Co Asset Management US reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 20,832 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $2.1M.
  • Rothschild & Co Asset Management US first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's CUBIST PHARMACEUTICALS INC position peaked at $11.3M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2015, filed 15 May 2015.